Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer

BACKGROUND: ETS variant gene 6 (ETV6) is a putative tumor suppressor and repressed by epidermal growth factor receptor (EGFR) signaling in prostate cancer. Since EGFR antagonists seem ineffective in castration-resistant prostate cancer (CRPC), we aim to study the role of ETV6 in the development of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Yuan-Chin, Zeng, Tao, Abou-Kheir, Wassim, Yeh, Hsiu-Lien, Yin, Juan Juan, Lee, Yi-Chao, Chen, Wei-Yu, Liu, Yen-Nien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817720/
https://www.ncbi.nlm.nih.gov/pubmed/29455655
http://dx.doi.org/10.1186/s12943-018-0785-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817720/
https://www.ncbi.nlm.nih.gov/pubmed/29455655
http://dx.doi.org/10.1186/s12943-018-0785-1

Ejemplares similares